191 related articles for article (PubMed ID: 2123390)
1. Antimicrobial susceptibility and beta-lactamase characterization of Branhamella catarrhalis isolates from 1983/1984 and 1988.
Christensen JJ; Keiding J; Bruun B
APMIS; 1990 Nov; 98(11):1039-44. PubMed ID: 2123390
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis.
Esel D; Ay-Altintop Y; Yagmur G; Gokahmetoglu S; Sumerkan B
Clin Microbiol Infect; 2007 Oct; 13(10):1023-5. PubMed ID: 17608812
[TBL] [Abstract][Full Text] [Related]
3. [Molecular characterization of BRO beta-lactamases of Moraxella catarrhalis strains isolated from carrier children].
Köseoğlu O; Ergin A; Gürkan Aydin N; Hasçelik G
Mikrobiyol Bul; 2004 Oct; 38(4):335-40. PubMed ID: 15700658
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
Pottumarthy S; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
[TBL] [Abstract][Full Text] [Related]
5. The frequency of BRO β-lactamase and its relationship to antimicrobial susceptibility and serum resistance in Moraxella catarrhalis.
Saito R; Nonaka S; Fujinami Y; Matsuoka S; Nakajima S; Nishiyama H; Okamura N
J Infect Chemother; 2014 Jan; 20(1):6-8. PubMed ID: 24462416
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibility of Branhamella catarrhalis to antibiotics].
Leszczyńska K; Jakoniuk P; Sacha PT; Zalewska M; Wieczorek P
Med Dosw Mikrobiol; 2004; 56(3):231-7. PubMed ID: 15773499
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial resistance of Moraxella catarrhalis isolates in Taiwan.
Hsu SF; Lin YT; Chen TL; Siu LK; Hsueh PR; Huang ST; Fung CP
J Microbiol Immunol Infect; 2012 Apr; 45(2):134-40. PubMed ID: 22154675
[TBL] [Abstract][Full Text] [Related]
8. In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora.
Kaieda S; Yano H; Okitsu N; Hosaka Y; Okamoto R; Inoue M; Takahashi H
Int J Pediatr Otorhinolaryngol; 2005 Apr; 69(4):479-85. PubMed ID: 15763284
[TBL] [Abstract][Full Text] [Related]
9. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
Texier-Maugein J; Escoubas J; Fouche J; Mormede M
Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
[TBL] [Abstract][Full Text] [Related]
10. Characterization of BRO enzymes and beta-lactamase transfer of Moraxella (Branhamella) catarrhalis isolated in Japan.
Ikeda F; Yokota Y; Mine Y; Yamada T
Chemotherapy; 1993; 39(2):88-95. PubMed ID: 8458251
[TBL] [Abstract][Full Text] [Related]
11. beta-Lactam resistance and beta-lactamase isoforms of Moraxella catarrhalis isolates in Taiwan.
Fung CP; Lee SC; Liu PY; Jang TN; Wong FD; Kuo BI; Liu CY; Liu YC
J Formos Med Assoc; 1998 Jul; 97(7):453-7. PubMed ID: 9700241
[TBL] [Abstract][Full Text] [Related]
12. BRO beta-lactamase alleles, antibiotic resistance and a test of the BRO-1 selective replacement hypothesis in Moraxella catarrhalis.
Levy F; Walker ES
J Antimicrob Chemother; 2004 Feb; 53(2):371-4. PubMed ID: 14729761
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of restriction endonuclease analysis of BRO beta-lactamases in clinical and carrier isolates of Moraxella catarrhalis.
Köseoglu O; Ergin A; Hascelik G
Scand J Infect Dis; 2004; 36(6-7):431-4. PubMed ID: 15307563
[TBL] [Abstract][Full Text] [Related]
14. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
[TBL] [Abstract][Full Text] [Related]
15. bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults.
Khan MA; Northwood JB; Levy F; Verhaegh SJ; Farrell DJ; Van Belkum A; Hays JP
J Antimicrob Chemother; 2010 Jan; 65(1):91-7. PubMed ID: 19889789
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98).
Sader HS; Gales AC; Granacher TD; Pfaller MA; Jones RN;
Braz J Infect Dis; 2000 Oct; 4(5):245-54. PubMed ID: 11063556
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Moraxella catarrhalis isolates to beta-lactam antibiotics in relation to beta-lactamase pattern.
Fung CP; Yeo SF; Livermore DM
J Antimicrob Chemother; 1994 Feb; 33(2):215-22. PubMed ID: 8182002
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility to β-lactam antibiotics and production of BRO β-lactamase in clinical isolates of Moraxella catarrhalis from a Japanese hospital.
Yamada K; Arai K; Saito R
J Microbiol Immunol Infect; 2017 Jun; 50(3):386-389. PubMed ID: 28057435
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
[TBL] [Abstract][Full Text] [Related]
20. The beta-lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish children.
Ejlertsen T; Skov R
APMIS; 1996; 104(7-8):557-62. PubMed ID: 8920809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]